
| Serial Number | 97074234 |
| Word Mark | VITROSCREEN |
| Filing Date | Thursday, October 14, 2021 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, March 1, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Stem cells; Cells for medical use; Stem cells for medical purposes; Living cells for medical use; Human allograft tissue; Vascular grafts; Moleskin for medical purposes; Bone filling products made from living tissue; Biological tissue for implantation; Biological preparations for medical purposes; Biological tissue cultures for medical purposes; Cultures for medical use |
| Pseudo Mark | VITRO SCREEN |
| Goods and Services | Stem cell research; Scientific services relating to the isolation and cultivation of human tissues and cells; Biological research; Biological laboratory services; Biological research and analysis; Biology consultancy; Scientific research relating to biology; Preparation of biological samples for research purposes; Preparation of biological samples for testing and analysis in research laboratories; Industrial and analysis research, including analysis of cosmetic and pharmaceutical products; Research on the subject of pharmaceuticals; Cosmetic research; Medical research; Clinical research; Biological research; Technological research; Research relating to biotechnology; Genetic research; Biological research, clinical research and medical research; Research laboratories; Biomedical research services; Scientific research relating to cosmetics; Pharmaceutical research services; Cosmetics research for others; Scientific research in the field of pharmacy; Chemical research; Biochemical research and development; Scientific research relating to genetics; Cell separation research services; Medical and pharmacological research services; Research relating to molecular sciences; DNA screening for scientific research purposes; Analysis of human tissues for medical research; Technical consultancy in relation to research services relating to foods and dietary supplements |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 3, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, May 21, 2001 |
| First Use In Commerce Date | Wednesday, October 11, 2017 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 3, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, May 21, 2001 |
| First Use In Commerce Date | Wednesday, October 11, 2017 |
| Party Name | Vitroscreen S.r.l. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Milano 20149 IT |
| Event Date | Event Description |
| Thursday, March 2, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Wednesday, March 1, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Wednesday, March 1, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, August 16, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, August 16, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, August 16, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, July 20, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, November 3, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, October 18, 2021 | NEW APPLICATION ENTERED |